Cheolhee Won, CEO
- M.S. in Dental Science, Ph.D. in Medicine from Seoul National University
- Research Professor at Seoul National University (former)
- Committee member of Korean Society for Nanomedicine (current)
- Seoul National University Bio-CEO Program
Expert in BD and management in biotechnology and pharmacology who has research experience
in somatic cell nuclear transfer, stem cell, cancer stem cell, immuno oncology,
immune checkpoint inhibitor, and Fc-fusion protein development and
understands unmet needs and pros and cons of each field.